Title | Authors | Journal | Date | Link |
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma | Mai EK et al. | Blood Cancer J. | 4 January 2023 | |
C/EBPβ-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells | de Laval B et al. | Cell Stem Cell. | 5 January 2023 | |
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome | Eckardt JN et al. | Blood Cancer J. | 24 January 2023 | |
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Denkinger CM et al. | Nat Cancer. | January 2023 | |
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells | García-Guerrero E et al. | Haematologica. | 1 February 2023 | |
Engineering CD20 CARs with a Twist | Scheller L et al . | Cancer Immunol Res. | 3 February 2023 | |
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy | Arndt C et al. | Front Pharmacol. | 3 February 2023 | |
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia | Zhou F et al . | Cancer Discov | 6 February 2023 | |
Medical microrobots in reproductive medicine from the bench to the clinic | Nauber R et al. | Nat Commun. | 9 February 2023 | |
Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes | Gainullina A et al. | Cell Rep. | 28 February 2023 | |
Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency | Braun T et al. | Front Immunol. | 24 March 2023 | |
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia | Mian SA et al. | Sci Transl Med. | March 2023 | |
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial | Bornhäuser M et al. | JAMA Oncol. | 1 April 2023 | |
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells | Saleh HA et al. | Front Immunol. | 14 April 2023 | |
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes | Zeidan AM et al. | Blood. | 27 April 2023 | |
Risk prediction in MDS: independent validation of the IPSS-M-ready for routine? | Baer C et al. | Leukemia. | April 2023 | |
Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy | Rupp L et al. | Front Immunol. | 16 May 2023 | |
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome | Georgi JA et al. | Blood Cancer J. | 26 May 2023 | |
Novel evidence that the ABO blood group shapes erythropoiesis and results in higher hematocrit for blood group B carriers | Kronstein-Wiedemann R et al. | Leukemia. | May 2023 | |
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells | Chihara D et al. | Haematologica | 1 June 2023 | |
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells | Kegler A et al. | Front Immunol. | 13 June 2023 | |
CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability | Mircetic J et al. | Small Methods. | June 2023 | |
Precise excision of HTLV-1 provirus with a designer-recombinase | Rojo-Romanos T et al. | Mol Ther. | 5 July 2023 | |
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial | Platzbecker U et al. | Lancet | July 2023 | |
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia | Kayser S et al. | Haematologica. | 1 August 2023 | |
Teclistamab impairs detection of BCMA CAR-T cells | Glatte B et al. | Blood Adv. | 8 August 2023 | |
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma | Heim C et al. | Front Immunol. | 18 August 2023 | |
Editorial: Translating NK cell scientific research to clinical product manufacturing | Ullrich E et al. | Front Immunol. | August 2023 | |
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial | Ruhnke L et al. | Haematologica. | 1 September 2023 | |
Graft- versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT | Devillier R et al. | Haematologica. | 1 September 2023 | |
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo | Silvestre RN et al. | Front. Immunol. | 25 September 2023 | |
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy | Staudt S et al. | Front. Immunol. | September 2023 | |
FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia | Peschke JC et al. | Br J Haematol. | September 2023 | |
Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer | Shankar NM et al. | Front. Immunol. | 11 October 2023 | |
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors | Dragon AC et al. | Front. Immunol. | 17 October 2023 | |
Quantification of evolved DNA-editing enzymes at scale with DEQSeq | Schmitt LT et al. | Genome Biol. | 6 November 2023 | |
M-CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation | Kandalla PK et al. | EMBO Mol Med | 8 November 2023 | |
Ruscher C, Patzina-Mehling C, Melchert J, Graff SL, McFarland SE, Hieke C, Kopp A, Prasser A, Tonn T, Schmidt M, Isner C, Drosten C, Werber D, Corman VM, Junglen S | Emde-Rajaratnam M et al. | Front Immunol. | 15 November 2023 | |
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells | Nelde A et al. | Blood Cancer Discov. | 1 November 2023 | |
CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma | Ciulean OS et al. | Front Immunol. | 10 November 2023 | |
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations | Ammar D et al. | Front Immunol. | 24 November 2023 | |
Ecological and clinical evidence of the establishment of West Nile virus in a large urban area in Europe, Berlin, Germany, 2021 to 2022 | Ruscher C et al. | Euro Surveill | November 2023 | |
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial | Liebers N et al. | Nat Cancer. | 4 December 2023 | |
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment | Loureiro LR et al. | J Exp Clin Cancer Res. | 15 December 2023 | |
Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells | Front Immunol. | Front Immunol. | 15 December 2023 | |
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia | Eckardt JN et al. | Leukemia | December 2023 |
